13:33:36 EDT Mon 17 Aug 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Alzai Health Corp
Symbol ALZI
Shares Issued 65,647,682
Close 2026-08-12 C$ 0.355
Market Cap C$ 23,304,927
Recent Sedar+ Documents

Alzai Health hires Euro Digital for marketing services

2026-08-17 11:41 ET - News Release

Mr. Hayim Raclaw reports

ALZAI HEALTH CORP. ANNOUNCES MARKETING SERVICES AGREEMENT

Alzai Health Corp. has entered into a services agreement dated Aug. 12, 2026, with Euro Digital Media Ltd. (address: 71-75 Shelton St., Covent Garden, London, United Kingdom, WC2H 9JQ) pursuant to which Euro Digital will provide market awareness and digital marketing services to the company.

Under the terms of the services agreement, Euro Digital will create campaigns, ad groups, text ads and display ads, perform detailed keyword research, develop and manage remarketing campaigns, dynamically optimize keyword sets, conduct continuing bid management, optimize keyword options, co-ordinate with on-line advertisers and marketers corresponding to the company's on-line marketing objectives, place display advertisements, and create landing pages for advertising campaigns.

The company has agreed to pay Euro Digital a fee of $425,000 (U.S.), plus any applicable local taxes, for the services. The services are expected to be provided over a term of 12 months following Toronto Stock Exchange approval (defined below), or until budget exhaustion, whichever occurs first.

The company will not issue any securities to Euro Digital as compensation for its marketing services. As of the date hereof, to the company's knowledge, Euro Digital, including its principal, does not own any securities of the company and has an arm's-length relationship with the company. The services agreement is subject to the approval of the TSX Venture Exchange.

About Alzai Health Corp.

Alzai Health is a health care technology company developing non-invasive, artificial-intelligence-driven disease risk identification solutions using routine health care data. The company's proprietary platform is designed to identify individuals at elevated risk for disease before clinical diagnosis, enabling earlier intervention opportunities and supporting improved patient outcomes. Alzai's technology has been validated on large-scale health care data sets and is designed for integration into existing health care infrastructure, including electronic medical record systems, cloud-based environments and enterprise health care platforms.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.